14 results
Thumbnail

D3.101 - Etoricoxib Associated Fixed Drug Eruption: A Case Series from a Tertiary Allergy and Clinical Immunology Centre, United Arab Emirates

Thumbnail

D3.93 - Clinical Efficacy of Tezepelumab in a Patient with Severe Refractory Mixed Asthma: A Case Report from Kazakhstan

Thumbnail

D3.95 - Hidden in everyday cosmetics: Facial allergic contact dermatitis to fragrances

Thumbnail

D3.97 - Allergic contact dermatitis confirmed by repeated open application test in a 68‑year‑old patient

Thumbnail

D3.98 - An extended study for the multiple detection of IgE-mediated allergic reactions using microarray technology

Thumbnail

D3.104 - Molecular Co-Sensitization Mapping Using a 192-Line Multiplex IgE Platform

Thumbnail

D3.105 - Analysis of post-vaccination immunity in children with dermatology diseases receiving biologic and immunosuppressive therapy

Thumbnail

D3.107 - Comparison of Cupressaceae sensitization allergens in a large Spanish cohort

Thumbnail

D3.103 - Comprehensive Allergen Characterization for Standardized Basophil Activation Testing

Thumbnail

D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial

Thumbnail

D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial

Thumbnail

D3.438 - Clinical outcomes with navenibart according to baseline attack rate, body mass index, and age: results of the ALPHA-STAR trial

Thumbnail

D3.447 - Pre-clinical Toxicology and Immunogenicity Evidence as a Precursor of the Successful Phase I/IIA Study with VLP Peanut

Thumbnail

D3.448 - Use of Sebetralstat as Short-term Prophylaxis for Patients with Hereditary Angioedema: Results from the KONFIDENT-S Study